![The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the NCI of the National Institutes of Health. – The Albert Einstein College of Medicine](https://oncodaily.com/pub/uploads/2023/09/100-1280x784.png)
The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the NCI of the National Institutes of Health. – The Albert Einstein College of Medicine
The Albert Einstein College of Medicine, made the following post on LinkedIn:
“The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. Through NCI’s peer-review process, MECCC was awarded a five-year, $20 million Cancer Center Support Grant to advance the translation of novel cancer research into new treatments, new screening and diagnostic tools, and equitable access to care throughout the Bronx, Westchester county, and the lower Hudson Valley.
“We are deeply honored to be recognized for the unique and special contributions of our cancer center in the NCI’s portfolio of comprehensive cancer centers,” said Edward Chu, M.D., M.M.S., director of MECCC, Carol and Roger Einiger Professor of Cancer Medicine and professor of oncology, medicine, and molecular pharmacology at Albert Einstein College of Medicine, and vice-president of cancer medicine at Montefiore Medicine.”
For details click here
Source: The Albert Einstein College of Medicine / LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023